In this field, Sawant S et al. (2018) showed that the serum CD44 levels were significantly increased in oral cancer patients than in the controls (251 ± 69.3 ng/mL and 178 ± 29 ng/mL, respectively). This evidence concerns the gene CD44 and lip and oral cavity carcinoma.